BG107407A - Novel polymorph v of torasemide - Google Patents

Novel polymorph v of torasemide

Info

Publication number
BG107407A
BG107407A BG107407A BG10740702A BG107407A BG 107407 A BG107407 A BG 107407A BG 107407 A BG107407 A BG 107407A BG 10740702 A BG10740702 A BG 10740702A BG 107407 A BG107407 A BG 107407A
Authority
BG
Bulgaria
Prior art keywords
torasemide
novel polymorph
preparation
modifications
polymorph
Prior art date
Application number
BG107407A
Other languages
Bulgarian (bg)
English (en)
Inventor
Darko Filic
Miljenco Dumic
Bozena Klepic
Aleksandar Danilovski
Marijan Tudja
Original Assignee
Pliva, Farmaceutska Industrija
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva, Farmaceutska Industrija filed Critical Pliva, Farmaceutska Industrija
Publication of BG107407A publication Critical patent/BG107407A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BG107407A 2000-05-19 2002-12-19 Novel polymorph v of torasemide BG107407A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20000328A HRP20000328A2 (en) 2000-05-19 2000-05-19 Novel polymorph v of torasemide
PCT/HR2000/000033 WO2001087841A1 (en) 2000-05-19 2000-09-25 Novel polymorph v of torasemide

Publications (1)

Publication Number Publication Date
BG107407A true BG107407A (en) 2004-01-30

Family

ID=10947111

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107407A BG107407A (en) 2000-05-19 2002-12-19 Novel polymorph v of torasemide

Country Status (32)

Country Link
US (2) US7241782B1 (de)
EP (1) EP1283828B1 (de)
JP (1) JP2003533512A (de)
KR (1) KR20030016267A (de)
CN (1) CN1520403A (de)
AP (1) AP2002002679A0 (de)
AR (1) AR028840A1 (de)
AT (1) ATE342890T1 (de)
AU (1) AU2000274381A1 (de)
BG (1) BG107407A (de)
BR (1) BR0015877A (de)
CA (1) CA2409699A1 (de)
CZ (1) CZ20024104A3 (de)
DE (1) DE60031450T2 (de)
DZ (1) DZ3356A1 (de)
EA (1) EA005003B1 (de)
EE (1) EE200200637A (de)
GE (1) GEP20043321B (de)
HR (1) HRP20000328A2 (de)
HU (1) HUP0302135A2 (de)
IL (1) IL152810A0 (de)
IS (1) IS6620A (de)
MA (1) MA25748A1 (de)
MX (1) MXPA02011402A (de)
NO (1) NO20025509L (de)
NZ (1) NZ522544A (de)
PL (1) PL358257A1 (de)
SK (1) SK17712002A3 (de)
TR (1) TR200202544T2 (de)
WO (1) WO2001087841A1 (de)
YU (1) YU84202A (de)
ZA (1) ZA200209181B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781461C (en) * 1999-08-11 2006-02-23 Teva Pharmaceutical Industries Ltd. Torsemide polymorphs
IN192178B (de) 2001-08-03 2004-03-06 Ranbaxy Lab
US7067385B2 (en) * 2003-09-04 2006-06-27 Micron Technology, Inc. Support for vertically oriented capacitors during the formation of a semiconductor device
CN1824647B (zh) * 2005-02-22 2011-04-20 田边三菱制药株式会社 (±)2-(二甲基氨基)-1-{[O-(m-甲氧基苯乙基)苯氧基]甲基}乙基氢琥珀酸酯盐酸盐的晶体
CN100421662C (zh) * 2005-11-08 2008-10-01 周卓和 托拉塞米分散片及其制备方法和应用
CN104370805B (zh) * 2013-08-13 2016-09-07 天津汉瑞药业有限公司 托拉塞米化合物
CN105949115A (zh) * 2016-05-26 2016-09-21 南京正科医药股份有限公司 一种新晶型托拉塞米
CN115417810B (zh) * 2022-09-22 2023-10-10 南京正科医药股份有限公司 一种托拉塞米晶型ⅰ的精制方法
CN117486789A (zh) * 2023-12-29 2024-02-02 江西中医药大学 一种托拉塞米共晶盐及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055650A (en) 1974-04-17 1977-10-25 A. Christiaens Societe Anonyme Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridines
GB1477664A (en) 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
IN182496B (de) * 1996-02-20 1999-04-17 Reddy Research Foundation
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US5914336A (en) * 1998-06-02 1999-06-22 Boehringer Mannheim Gmbh Method of controlling the serum solubility of orally administered torasemide and composition relating thereto

Also Published As

Publication number Publication date
IS6620A (is) 2002-11-14
NO20025509D0 (no) 2002-11-15
EA005003B1 (ru) 2004-10-28
EA200201236A1 (ru) 2003-04-24
AP2002002679A0 (en) 2002-12-31
BR0015877A (pt) 2003-04-29
NO20025509L (no) 2002-11-15
YU84202A (sh) 2006-05-25
CZ20024104A3 (cs) 2003-04-16
AR028840A1 (es) 2003-05-28
EP1283828B1 (de) 2006-10-18
HRP20000328A2 (en) 2002-02-28
MXPA02011402A (es) 2003-06-06
DZ3356A1 (en) 2001-11-22
GEP20043321B (en) 2004-04-13
DE60031450D1 (de) 2006-11-30
ATE342890T1 (de) 2006-11-15
EP1283828A1 (de) 2003-02-19
PL358257A1 (en) 2004-08-09
US7241782B1 (en) 2007-07-10
NZ522544A (en) 2004-07-30
SK17712002A3 (sk) 2003-05-02
HUP0302135A2 (hu) 2003-10-28
CA2409699A1 (en) 2001-11-22
JP2003533512A (ja) 2003-11-11
KR20030016267A (ko) 2003-02-26
CN1520403A (zh) 2004-08-11
IL152810A0 (en) 2003-06-24
ZA200209181B (en) 2004-02-12
TR200202544T2 (tr) 2003-03-21
US20070238759A1 (en) 2007-10-11
EE200200637A (et) 2004-04-15
AU2000274381A1 (en) 2001-11-26
MA25748A1 (fr) 2003-04-01
DE60031450T2 (de) 2007-09-20
WO2001087841A1 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
MY152846A (en) New salts of valsartan
AP2002002637A0 (en) Novel piperazine
WO2001032632A3 (en) Pharmaceutically active 4-substituted pyrimidine derivatives
ZA200305307B (en) Preparation of non-crystalline at atorvastatin calcium.
JO2646B1 (en) New differentiated cyclic compounds as beta - lactam inhibitors
WO2001096334A3 (en) Heteroarylalkanoic acids as integrin receptor antagonists
BG105485A (en) New crystal modification n of torasemide
CA2412047A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
BG107407A (en) Novel polymorph v of torasemide
AP2001002306A0 (en) Bridged piperazine derivatives.
HK1046902A1 (zh) 新型哌嗪基烷基硫代嘧啶衍生物，包含該衍生物的藥物組合物以及製備該活性物質的方法
YU70502A (sh) Amorfna modifikacija torasemida
MXPA01004457A (es) Derivados pirimidina novedosos y procesos para la preparacion de los mismos.
BR0115042A (pt) Ligandos de receptores de aminoalquilpirrolidina serotonina e composições, seus usos farmacêuticos, e processos para a sua sìntese
AU2001284476A1 (en) Novel crystals of 1,3,4-oxadiazole derivative, process for producing the crystals and medicines containing the same as the active ingredient
IL154625A0 (en) Novel crystals of n-hydroxy-2 (s)-methyl-5-ethoxymethoxy-4-(s)-[n-(4-phenoxyphenylcarbonyl) amino] pentanamide, process for their production and medicines containing the crystals as the active ingredient
WO2000063175A3 (en) Novel process
WO2002036554A3 (en) Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
SE9901338D0 (sv) Novel process